CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
Publishing timestamp: 2025-02-12 18:37:01
Summary
CVS Health CEO defends pharmacy middlemen, accuses drug manufacturers of keeping prices high in U.S. Lawmakers and President Trump have shown interest in cracking down on PBMs. CVS owns Caremark, one of the largest PBMs. Joyner claims PBMs help lower costs, but industry and lawmakers argue they pocket savings instead of passing them to patients. Pharmaceutical industry and lawmakers are investigating PBMs for driving up costs.
Sentiment: MIXED
Tickers: CVS,
Keywords: biotech and pharmaceuticals, health care industry, breaking news: business, cvs health corp, social issues, pharmaceuticals, biotechnology, united states, business, business news,